Volume 11 Issue 1
Jan.  2020
Turn off MathJax
Article Contents
Shen Guojie, Tu Zhenhua. Interpretation of Guide to the Quality and Safety of Organs for Transplantation (6th edition): biosafety early warning[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 98-103. doi: 10.3969/j.issn.1674-7445.2020.01.016
Citation: Shen Guojie, Tu Zhenhua. Interpretation of Guide to the Quality and Safety of Organs for Transplantation (6th edition): biosafety early warning[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 98-103. doi: 10.3969/j.issn.1674-7445.2020.01.016

Interpretation of Guide to the Quality and Safety of Organs for Transplantation (6th edition): biosafety early warning

doi: 10.3969/j.issn.1674-7445.2020.01.016
More Information
  • Corresponding author: Tu Zhenhua, Email: richardtu@163.com
  • Received Date: 2019-09-23
    Available Online: 2021-01-19
  • Publish Date: 2020-01-15
  • With the rapid development of organ donation and transplantation, it becomes increasingly important to improve the management system and ensure the quality and safety of organs for transplantation. Guide to the Quality and Safety of Organs for Transplantation (6th Edition) by European Committee provides the definitions of severe adverse reactions and severe adverse events in the perspective of biosafety early warning, delivers management and reporting processes, and encourages medical staff involved in organ transplantation to identify the adverse reactions and adverse events as soon as possible, and to carry out investigation, assessment and feedback. At the same time, it also systematically illustrates the warning and monitoring of organ transplantation risk, which is worthy of application in clinical study and practice.

     

  • loading
  • [1]
    BRETT KE, RITCHIE LJ, ERTEL E, et al. Quality metrics in solid organ transplantation: a systematic review[J]. Transplantation, 2018, 102(7):e308-e330. DOI: 10.1097/TP.0000000000002149.
    [2]
    SALMELA K. Quality and safety of organ transplantation[J]. Ann Transplant, 2004, 9(1):51-52.
    [3]
    GREEN M, COVINGTON S, TARANTO S, et al. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee[J]. Transplantation, 2015, 99(2):282-287. DOI: 10.1097/TP.0000000000000584.
    [4]
    MARAZUELA R, GARRIDO G, MATESANZ R. European Union and Spanish regulations on quality and safety of tissues and cells: overview and biovigilance[J]. Transplant Proc, 2009, 41(6):2044-2046. DOI: 10.1016/j.transproceed.2009.06.033.
    [5]
    European Committee (Partial Agreement) on Organ Transplantation (CD-P-TO) EDQM.移植器官质量与安全指南(原书第6版)[M].张雷, 译.北京: 科学出版社, 2019.
    [6]
    Directive 2010/45/EU of the European parliament and of the council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation [EB/OL]. (2016-01-30). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:207:0014:0029:EN:PDF.
    [7]
    ISON MG, HAGER J, BLUMBERG E, et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee[J]. Am J Transplant, 2009, 9(8): 1929-1935. DOI: 10.1111/j.1600-6143.2009.02700.x.
    [8]
    GARZONI C, ISON MG. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation[J]. Transplantation, 2011, 92(12):1297-1300. DOI: 10.1097/TP.0b013e318236cd02.
    [9]
    MILLER R, COVINGTON S, TARANTO S, et al. Communication gaps associated with donor-derived infections[J]. Am J Transplant, 2015, 15(1):259-264. DOI: 10.1111/ajt.12978.
    [10]
    GKIOKA V, TSIRIGOTIS P, SARRIS M, et al. Biovigilance for the quality and safety of medical products of human origin[J]. J Clin Med Res, 2018, 10(12):857-867. DOI: 10.14740/jocmr3549w.
    [11]
    SNYDER JJ, SALKOWSKI N, KIM SJ, et al. Developing statistical models to assess Transplant Outcomes Using National Registries: the process in the United States[J]. Transplantation, 2016, 100(2): 288-294. DOI: 10.1097/TP.0000000000000891.
    [12]
    KAYE S, BADDON A, JONES M, et al. A UK scheme for reporting serious adverse events and reactions associated with ocular tissue transplantation[J]. Cell Tissue Bank, 2010, 11(1):39-46. DOI: 10.1007/s10561-009-9139-y.
    [13]
    Notify Library[EB/OL]. (2016-01-30). http://www.notifylibrary.org.
    [14]
    GALLAGHER TH, WATERMAN AD, EBERS AG, et al. Patients' and physicians' attitudes regarding the disclosure of medical errors[J]. JAMA, 2003, 289(8):1001-1007. doi: 10.1001/jama.289.8.1001
    [15]
    ISON MG, NALESNIK MA. An update on donor-derived disease transmission in organ transplantation[J]. Am J Transplant, 2011, 11(6):1123-1130. DOI: 10.1111/j.1600-6143.2011.03493.x.
    [16]
    ISON MG, HOLL JL, LADNER D. Preventable errors in organ transplantation: an emerging patient safety issue?[J]. Am J Transplant, 2012, 12(9):2307-2312. DOI: 10.1111/j.1600-6143.2012.04139.x.
    [17]
    MATHUR AK, STEMPER-BARTKUS C, ENGHOLDT K, et al. Identifying patterns of adverse events of solid organ transplantation through departmental case reviews[J]. Mayo Clin Proc Innov Qual Outcomes, 2019, 3(3):335-343. DOI: 10.1016/j.mayocpiqo.2019.04.007.
    [18]
    ECHENIQUE IA, ISON MG. Update on donor-derived infections in liver transplantation[J]. Liver Transpl, 2013, 19(6):575-585. DOI: 10.1002/lt.23640.
    [19]
    VAN ASSCHE K, STERCKX S, LENNERLING A, et al. The relevance of directive 2010/53/EU for living organ donation practice: an ELPAT view[J]. Transplantation, 2015, 99(10):2215-2222. DOI: 10.1097/TP.0000000000000670.
    [20]
    LUMBRERAS C, SANZ F, GONZÁLEZ A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients[J]. Clin Infect Dis, 2001, 33(5):722-726. doi: 10.1086/322599
    [21]
    MARTINIÈRE K, LUCAS S, ZORZI P. Events and adverse reactions in biovigilance: descriptive analysis of French national data following a four-year practical experience[J]. Transfus Clin Biol, 2008, 15(4):179-189. DOI: 10.1016/j.tracli.2008.04.008.
    [22]
    CZERWIŃSKI J, ANTOSZKIEWICZ K, GRYGIEL K, et al. National Transplants Registry in Poland: early and long-term results of organ transplantations in the years 1998 to 2014[J]. Transplant Proc, 2016, 48(5):1407-1410. DOI: 10.1016/j.transproceed.2016.01.086.
    [23]
    CAMERON AM, SULLIVAN BE. Regulatory oversight in transplantation: there and back again[J]. JAMA Surg, 2013, 148(11):997-998. DOI: 10.1001/jamasurg.2013.2762.
    [24]
    SoHO V & S Guidance for competent authorities: communication and investigation of serious adverse events and reactions associated with human tissues and cells[EB/OL]. (2016-01-30). http://www.notifylibrary.org/sites/default/files/SOHO%20V%26S%20Communication%20and%20Investigation%20Guidance.pdf.
    [25]
    LEN O, GARZONI C, LUMBRERAS C, et al. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections[J]. Clin Microbiol Infect, 2014, 20(Suppl 7):10-18. DOI: 10.1111/1469-0691.12557.
    [26]
    STRONG DM. Tissue banking, biovigilance and the notify library[J]. Cell Tissue Bank, 2018, 19(2):187-195. DOI: 10.1007/s10561-017-9639-0.
    [27]
    FEHILY D. Sharing vigilance experience and knowledge globally - a preliminary overview of the Notify Library[J]. Cells Tissues Organs, 2013, 16:117-125.
    [28]
    STEWART DE, TLUSTY SM, TAYLOR KH, et al. Trends and patterns in reporting of patient safety situations in transplantation[J]. Am J Transplant, 2015, 15(12):3123-3133. DOI: 10.1111/ajt.13528.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article Metrics

    Article views (189) PDF downloads(25) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return